Print

Fidelity-Backed Fluidigm Corporation May Delay IPO as Startup Deals Falter  
2/22/2010 7:28:50 AM

Bookmark and Share

Bloomberg -- Fluidigm Corp., the biotechnology- equipment maker that had planned an initial public offering for this year, may postpone the share sale after 2010’s first IPOs stumbled, its chief executive officer said.

//-->